From: Identification of key pseudogenes in nasopharyngeal carcinoma based on RNA-Seq analysis
 | Patient | Age | Gender | Diagnosis | CKpan | P63 | P40 | KI67 | LCA | EGFR | P16 | 34βE12 | EBER | EBV |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Primary NPC | SXL | 49 | F | typeII,typeIII | + | + | * | 30–40%+ | – | + | – | * | + | * |
HCH | 65 | M | typeII,typeIII | + | + | * | 50%+ | – | + | – | + | + | + | |
WCZ | 33 | M | typeII,typeIII | + | + | + | 60–70%+ | – | + | – | + | + | * | |
JYT | 57 | M | typeII,typeIII | + | + | partial + | 10–20%+ | – | + | – | + | + | + | |
LSB | 75 | M | typeII,typeIII | + | + | + | 40%+ | – | + | – | + | + | + | |
ZLZ | 61 | F | typeI | + | + | + | 30–40%+ | – | + | partial + | + | + | + | |
CMW | 70 | M | typeI | + | + | + | 40%+ | – | + | + | + | + | * | |
ZQX | 70 | F | typeII,typeIII | + | + | + | 70%+ | – | + | – | + | + | * | |
WHW | 40 | M | typeII,typeIII | + | + | + | 20%+ | – | + | partial + | + | + | + | |
XZP | 37 | F | typeII,typeIII | + | + | + | 30%+ | – | + | – | + | + | + | |
GSW | 51 | M | typeII,typeIII | + | partial + | partial + | 40%+ | – | + | – | + | + | + | |
ZXE | 51 | F | typeI | + | + | partial + | 30%+ | – | + | – | + | + | + | |
LYG | 42 | M | typeII,typeIII | + | + | partial + | 60%+ | – | + | – | + | + | + | |
Recurrent NPC | LJQ | 55 | M | typeII,typeIII | + | + | + | 40%+ | * | + | – | * | + | * |
ZXF | 61 | M | typeI | + | + | + | 50%+ | – | + | * | * | + | * | |
LWM | 56 | M | typeII,typeIII | + | + | + | 70–80%+ | * | + | – | + | + | * | |
WJL | 49 | M | typeI | + | + | + | 50%+ | * | * | * | * | + | * | |
ZCZ | 47 | M | typeI | + | + | + | 50%+ | * | * | – | * | – | + | |
PJ | 54 | M | typeI | + | + | + | 70%+ | * | + | * | * | + | * |